191 related articles for article (PubMed ID: 24219981)
1. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
[TBL] [Abstract][Full Text] [Related]
2. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
[TBL] [Abstract][Full Text] [Related]
3. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
4. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.
de Kruijf EM; van Nes JG; van de Velde CJ; Putter H; Smit VT; Liefers GJ; Kuppen PJ; Tollenaar RA; Mesker WE
Breast Cancer Res Treat; 2011 Feb; 125(3):687-96. PubMed ID: 20361254
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
6. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer.
Chen Y; Zhang L; Liu W; Liu X
Biomed Res Int; 2015; 2015():589301. PubMed ID: 26609529
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
Eggen T; Arnes M; Moe B; Straume B; Orbo A
Int J Gynecol Pathol; 2007 Oct; 26(4):447-56. PubMed ID: 17885497
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery.
Pongsuvareeyakul T; Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Intaraphet S; Siriaunkgul S
Asian Pac J Cancer Prev; 2015; 16(10):4363-8. PubMed ID: 26028100
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72-kDa metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Romanini C; Biagini G
Gynecol Oncol; 1996 Apr; 61(1):83-9. PubMed ID: 8626123
[TBL] [Abstract][Full Text] [Related]
13. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
14. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
15. The tumor-stroma ratio is an independent predictor for survival in nasopharyngeal cancer.
Zhang XL; Jiang C; Zhang ZX; Liu F; Zhang F; Cheng YF
Oncol Res Treat; 2014; 37(9):480-4. PubMed ID: 25231688
[TBL] [Abstract][Full Text] [Related]
16. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
[TBL] [Abstract][Full Text] [Related]
19. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?
Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH
Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586
[TBL] [Abstract][Full Text] [Related]
20. Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions.
Wagner AE; Pappas L; Ghia AJ; Gaffney DK
Gynecol Oncol; 2013 Jun; 129(3):517-21. PubMed ID: 23528928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]